Bioinformatics profiling integrating a three immune-related long non-coding RNA signature as a prognostic model for clear cell renal cell carcinoma
Open Access
- 13 May 2020
- journal article
- research article
- Published by Springer Nature in Cancer Cell International
- Vol. 20 (1) , 1-10
Abstract
Background: Renal cell carcinoma (RCC) is one of the most common aggressive malignant tumors in urogenital system, and the clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal carcinoma. Immune related long non-coding RNAs (IRlncRs) plentiful in immune cells and immune microenvironment (IME) are potential in evaluating prognosis and assessing the effects of immunotherapy. A completed and meaningful IRlncRs analysis based on abundant ccRCC gene samples from The Cancer Genome Atlas (TCGA) will provide insight in this field. Methods: Based on the TCGA dataset, we integrated the expression profiles of IRlncRs and overall survival (OS) in the 611 ccRCC patients. The immune score of each sample was calculated based on the expression level of immune-related genes and used to identify the most meaningful IRlncRs. Survival-related IRlncRs (sIRlncRs) was estimated by calculating the algorithm of difference and COX regression analysis in ccRCC patients. Based on the median immune-related risk score (IRRS) developed from the screened sIRlncRs, the high-risk and low-risk components were distinguished. Functional annotation was detected by gene set enrichment analysis (GSEA) and principal component analysis (PCA), and the immune composition and purity of the tumor was evaluated by microenvironment cell population records. The expression levels of three sIRlncRs were verified in various tissues and cell lines. Results: A total of 39 IRlncRs were collected by Pearson correlation analyses among immune score and the lncRNA expression. A total of 7 sIRlncRs were significantly associated with the clinical outcomes of ccRCC patients. Three sIRlncRs (ATP1A1-AS1, IL10RB-DT and MELTF-AS1) with the most significant prognostic values were enrolled to build the IRRS model in which the OS of in the high-risk group was shorter than that in the low-risk group. The IRRS was identified as an independent prognosis factor and correlated with the OS. The high-risk group and low-risk group illustrated different distributions in PCA and different immune status in GSEA. Besides, we found the more significant expression in certain ccRCC cell lines and tumor tissues of ccRCC patients compared with the HK-2 and adjacent tissues respectively. Additionally, the expression levels of lncR-MELTF-AS1 and IL10RB-DT were remarkably enhanced along the more advanced T-stages, but the lncR-ATP1A1-AS1 showed the inverse gradient. Conclusion: Our results demonstrate some sIRlncRs with remark clinical relevance show the latent monitoring and prognosis values for ccRCC patients and may provide new insight in immunological researches and treatment strategies of ccRCC patients.Keywords
All Related Versions
This publication has 29 references indexed in Scilit:
- Mechanisms of resistance to mTOR inhibitorsCritical Reviews in Oncology/Hematology, 2020
- EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell CarcinomaCancers, 2020
- Integrated Proteogenomic Characterization of Clear Cell Renal Cell CarcinomaCell, 2019
- LncRNA MCM3AP-AS1 Regulates Epidermal Growth Factor Receptor and Autophagy to Promote Hepatocellular Carcinoma Metastasis by Interacting with miR-455DNA and Cell Biology, 2019
- Bioinformatics profiling utilized a nine immune‐related long noncoding RNA signature as a prognostic target for pancreatic cancerJournal of Cellular Biochemistry, 2019
- Immune associated LncRNAs identify novel prognostic subtypes of renal clear cell carcinomaMolecular Carcinogenesis, 2018
- Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell CarcinomaEuropean Urology, 2018
- NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell deathNature Immunology, 2018
- Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell CarcinomaCellular Physiology and Biochemistry, 2018
- An Immune-Related Six-lncRNA Signature to Improve Prognosis Prediction of Glioblastoma MultiformeMolecular Neurobiology, 2017